Patents by Inventor Julie Medina

Julie Medina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis
    Patent number: 10981977
    Abstract: The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or is therapy.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: April 20, 2021
    Assignees: GENEURO SA, THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Hervé Perron, Julie Medina, Avindra Nath, Joseph Perry Steiner, Wenxue Li, Myoung-Hwa Lee
  • Antiretroviral drug targeting human endogenous retrovirus
    Patent number: 10894820
    Abstract: The invention relates to an antibody, a fragment or a derivative thereof, for use as an antiretroviral drug targeting a virus belonging to human endogenous retroviruses type W (HERV-W), wherein said antibody, fragment or derivative thereof is directed against HERV-W Envelope protein (HERV-W Env). The invention also relates to a composition comprising said antibody and a retroviral reverse-transcriptase inhibitory drug, for use as an antiretroviral drug targeting a virus belonging to HERV-W.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: January 19, 2021
    Assignee: GENEURO SA
    Inventors: Herve Perron, Francois Curtin, Alois Lang, Raphael Faucard, Julie Medina, Alexandra Madeira, Nadege Gehin
  • ANTI-HERV-K ENVELOPE ANTIBODY AND USES THEREOF
    Publication number: 20200308258
    Abstract: The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or is therapy.
    Type: Application
    Filed: June 17, 2020
    Publication date: October 1, 2020
    Inventors: Hervé PERRON, Julie MEDINA, Avindra NATH, Joseph Perry Steiner, Wenxue LI, Myoung-Hwa LEE
  • Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody
    Patent number: 10723787
    Abstract: The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or in therapy.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: July 28, 2020
    Assignees: GENEURO SA, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Hervé Perron, Julie Medina, Avindra Nath, Joseph Perry Steiner, Wenxue Li, Myound-Hwa Lee
  • ANTI-HERV-K ENVELOPE ANTIBODY AND USES THEREOF
    Publication number: 20190345232
    Abstract: The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or in therapy.
    Type: Application
    Filed: January 19, 2018
    Publication date: November 14, 2019
    Inventors: Hervé PERRON, Julie MEDINA, Avindra NATH, Joseph Perry Steiner, Wenxue LI, Myound-Hwa LEE
  • Antiretroviral Drug Targeting Human Endogenous Retrovirus
    Publication number: 20190263895
    Abstract: The invention relates to an antibody, a fragment or a derivative thereof, for use as an antiretroviral drug targeting a virus belonging to human endogenous retroviruses type W (HERV-W), wherein said antibody, fragment or derivative thereof is directed against HERV-W Envelope protein (HERV-W Env). The invention also relates to a composition comprising said antibody and a retroviral reverse-transcriptase inhibitory drug, for use as an antiretroviral drug targeting a virus belonging to HERV-W.
    Type: Application
    Filed: March 22, 2019
    Publication date: August 29, 2019
    Inventors: Herve Perron, Francois Curtin, Alois Lang, Raphael Faucard, Julie Medina, Alexandra Madeira, Nadege Gehin
  • Production of infectious influenza viruses
    Patent number: 9982240
    Abstract: The invention relates to a method for producing influenza infectious viruses wherein CHO cells are infected with a seed of infectious influenza virus which has been generated by transfecting cells with an appropriate set of expression vectors. The invention also relates to a recombination cassette, and to a vector comprising said recombination cassette, that may be used in methods for producing infectious viruses, and particularly in the method according to the invention.
    Type: Grant
    Filed: July 29, 2013
    Date of Patent: May 29, 2018
    Assignee: Sanofi Pasteur
    Inventors: Isabelle Legastelois, Julie Medina, Catherine Moste
  • Antiretroviral Drug Targeting Human Endogenous Retrovirus
    Publication number: 20170101461
    Abstract: The invention relates to an antibody, a fragment or a derivative thereof, for use as an antiretroviral drug targeting a virus belonging to human endogenous retroviruses type W (HERV-W), wherein said antibody, fragment or derivative thereof is directed against HERV-W Envelope protein (HERV-W Env). The invention also relates to a composition comprising said antibody and a retroviral reverse-transcriptase inhibitory drug, for use as an antiretroviral drug targeting a virus belonging to HERV-W.
    Type: Application
    Filed: May 27, 2015
    Publication date: April 13, 2017
    Inventors: Herve Perron, Francois Curtin, Alois Lang, Raphael Faucard, Julie Medina, Alexandra Madeira, Nadege Gehin
  • PRODUCTION OF INFECTIOUS INFLUENZA VIRUSES
    Publication number: 20150191703
    Abstract: The invention relates to a method for producing influenza infectious viruses wherein CHO cells are infected with a seed of infectious influenza virus which has been generated by transfecting cells with an appropriate set of expression vectors. The invention also relates to a recombination cassette, and to a vector comprising said recombination cassette, that may be used in methods for producing infectious viruses, and particularly in the method according to the invention.
    Type: Application
    Filed: July 29, 2013
    Publication date: July 9, 2015
    Inventors: Isabelle Legastelois, Julie Medina, Catherine Moste